Researchers from Senelix Co. Ltd. described the preclinical characterization of the novel adiponectin receptor protein 1/2 (ADIPOR1/2) agonist SL-100, which is being developed for the treatment of dry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback